Drug Profile
LEO 15520
Alternative Names: Inflammation therapy - LEO Pharma; Inflammatory disorders therapy - LEO Pharma; LEO-15520Latest Information Update: 08 Apr 2008
Price :
$50
*
At a glance
- Originator LEO Pharma
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 08 Apr 2008 Discontinued - Phase-I for Inflammation in Denmark (PO)
- 09 Nov 2006 Phase-I clinical trials in Inflammation in Denmark (PO)
- 26 Sep 2005 Preclinical trials in Inflammation in Denmark (PO)